Market News & Trends
Immune Response BioPharma to Develop In-House Sales Force for Blockbuster Vaccine
New Jersey-based Immune Response BioPharma, Inc. recently announced its plans to create an in-house sales force for Remune, its HIV vaccine. Remune is a therapeutic…
Mexico’s Healthcare Market Value to Reach Almost $28 Billion by 2020, says GlobalData
LONDON, UK (GlobalData), 7 August 2014 - Mexico’s pharmaceutical and medical devices industries will be worth approximately $22.5 billion and $5.4 billion by 2020, respectively,…
Lubrizol Acquires Leading Manufacturer in Global Device Industry
The Lubrizol Corporation recently announced it has acquired Vesta, a leading contract manufacturer for the global medical device industry. This acquisition broadens Lubrizol's life science…
ACS Treatment Market to More Than Triple From $12.3 Billion to $43.4 Billion
The launch of several drugs with “extraordinary blockbuster potential” will cause the acute coronary syndrome (ACS) treatment market to more than triple in value, from…
Ready-to-Use EZ-Fit Filtration Unit From EMD Millipore Leverages Industry Leading Technology
EMD Millipore has launched the EZ-Fit Filtration Unit, a ready-to-use, disposable filtration device for bioburden testing. The system is more efficient than traditional methods, resulting…
Harlan Provides Expertise for Biologics & Biosimilars
Harlan Laboratories, Ltd. is prepared to meet the global demand for development programs in novel biologics and biosimilars. While the US FDA is slower to…
ZIOPHARM Oncology & Solasia Pharma Announce Global License & Collaboration Agreement
ZIOPHARM Oncology & Solasia Pharma Announce Global License & Collaboration Agreement ZIOPHARM Oncology, Inc. and Solasia Pharma K.K. recently announced an amendment and restatement of…
Allied Minds & Bristol-Myers Squibb Form New Enterprise
Allied Minds & Bristol-Myers Squibb Form New Enterprise Allied Minds and Bristol-Myers Squibb Company recently announced the formation of Allied-Bristol Life Sciences LLC, a new…
ACS Treatment Market to More Than Triple From $12.3 Billion to $43.4 Billion
The launch of several drugs with “extraordinary blockbuster potential” will cause the acute coronary syndrome (ACS) treatment market to more than triple in value, from…
Capsugel Study Provides First Substantive Reference Data on Key Quality Attributes of Empty Capsules
Capsugel recently published a study in AAPS’ PharmSciTech journal confirming that Capsugel capsules are suitable excipients for Quality-by-Design (QbD)-based product development and manufacturing. The study…
BioSpectra Offers Industry-Leading Custom Manufacturing Capabilities
BioSpectra, Inc. recently announced its ability to offer contract manufactured products for pharmaceutical, biopharmaceutical, and drug manufacturing markets direct from its newly opened FDA-registered facility…
Puma Biotechnology Reports Positive Breast Cancer Results
Shares of Puma Biotechnology Inc. more than tripled in after-hours trading Tuesday after the company reported positive clinical trial results of its experimental breast-cancer drug…
Specialty Vaccine Company PaxVax Secures Up to $60 Million in Financing
PaxVax, Inc., a specialty vaccine company focused on travel and biodefense, recently announced it has closed up to $50 million in secured debt financing from…
Bristol-Myers Squibb to Expand, Build Cancer Research Hub
Bristol-Myers Squibb Co. recently announced it has taken the first steps toward expanding its office space and building a cancer research hub for drugs that…
Horizon Discovery & Otsuka Sign Collaboration Agreement
Horizon Discovery Group plc recently announced its Horizon CombinatoRx division has been contracted by Otsuka Pharmaceutical Development and Commercialization, Inc. (OPDC) to perform in vitro…
West Expands Presence in Asian Markets
West Pharmaceutical Services, Inc. has dedicated its manufacturing plant in the Sri City Special Economic Zone (SEZ), where the company will expand its growing primary…
Mystic Pharmaceuticals Unveils Next Generation of Patient-Centric Sublingual Delivery Devices
Mystic Pharmaceuticals, Inc. recently announced the availability of its Javelin Sublingual drug delivery devices. Javelin Sublingual dispensers utilized Mystic’s VersiDoser and VRx2 platform technology, and…
Immatics Receives Almost $30-Million Final Tranche of Series D Funding
Immatics Biotechnologies GmbH recently announced it has received €22m (almost $30 million) to complete a Series D financing round. The company received €12m in October…
Hovione & Merrion Pharmaceuticals Announce Strategic Partnership
Hovione and Merrion Pharmaceuticals recently announced they have concluded a strategic partnership directed to the use of Merrion’s patented GIPET absorption enhancing technology by Hovione…
